volume 34 issue 1 pages 18-21

Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy

Publication typeJournal Article
Publication date2024-01-01
scimago Q3
wos Q3
SJR0.305
CiteScore3.0
Impact factor1.7
ISSN09599436, 1364551X
General Chemistry
Abstract
Polypeptide-based doxorubicin delivery systems were prepared and their physicochemical and functional properties, such as size, encapsulation efficiency, stability, release of doxorubicin in various media and cytotoxicity, were characterized. An in vivo study revealed an effective reduction of tumor growth when these systems were administered subcutaneously.
Found 
Found 

Top-30

Journals

1
2
Mendeleev Communications
2 publications, 25%
Drug Delivery and Translational Research
1 publication, 12.5%
Carbohydrate Polymers
1 publication, 12.5%
European Polymer Journal
1 publication, 12.5%
Medicine in Drug Discovery
1 publication, 12.5%
Polymers for Advanced Technologies
1 publication, 12.5%
Reactive and Functional Polymers
1 publication, 12.5%
1
2

Publishers

1
2
3
4
Elsevier
4 publications, 50%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 25%
Springer Nature
1 publication, 12.5%
Wiley
1 publication, 12.5%
1
2
3
4
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Sudareva N. N. et al. Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy // Mendeleev Communications. 2024. Vol. 34. No. 1. pp. 18-21.
GOST all authors (up to 50) Copy
Sudareva N. N., Tarasenko I. I., Suslov D. N., Suvorova O. M., Kolbe K. A., Yukina G. Y., Tyndyk M., Zmitrichenko Y. G., Korzhikova-Vlakh E. Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy // Mendeleev Communications. 2024. Vol. 34. No. 1. pp. 18-21.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2024.01.006
UR - https://doi.org/10.1016/j.mencom.2024.01.006
TI - Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy
T2 - Mendeleev Communications
AU - Sudareva, Natalia N
AU - Tarasenko, Irina I
AU - Suslov, Dmitry N
AU - Suvorova, Olga M
AU - Kolbe, Konstantin A
AU - Yukina, G. Yu.
AU - Tyndyk, Margarita
AU - Zmitrichenko, Yulia G.
AU - Korzhikova-Vlakh, Evgenia
PY - 2024
DA - 2024/01/01
PB - OOO Zhurnal "Mendeleevskie Soobshcheniya"
SP - 18-21
IS - 1
VL - 34
SN - 0959-9436
SN - 1364-551X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Sudareva,
author = {Natalia N Sudareva and Irina I Tarasenko and Dmitry N Suslov and Olga M Suvorova and Konstantin A Kolbe and G. Yu. Yukina and Margarita Tyndyk and Yulia G. Zmitrichenko and Evgenia Korzhikova-Vlakh},
title = {Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy},
journal = {Mendeleev Communications},
year = {2024},
volume = {34},
publisher = {OOO Zhurnal "Mendeleevskie Soobshcheniya"},
month = {jan},
url = {https://doi.org/10.1016/j.mencom.2024.01.006},
number = {1},
pages = {18--21},
doi = {10.1016/j.mencom.2024.01.006}
}
MLA
Cite this
MLA Copy
Sudareva, Natalia N., et al. “Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy.” Mendeleev Communications, vol. 34, no. 1, Jan. 2024, pp. 18-21. https://doi.org/10.1016/j.mencom.2024.01.006.